Even if they have been advised I believe Simes would be attending the closing plenary of the conference prior to making any announcement. If Teva is there as well they may release info afterwards. I believe both would want to sit in on the plenary. If I were CEO I know I would.
BIO CEO 2012 Closing Plenary
Inside the FDA
Tuesday, February 14th, 4:00pm-5:00pm
With PDUFA V reauthorization looming and the implementation of follow-on biologics legislation continuing, 2012 will be a big year for the FDA. Senior leaders from the FDA, BIO, and the industry will convene to discuss the legislative and regulatory environment, and what is in store for the FDA in the coming months and years.